<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-P30F7ISO</identifier><date>2008</date><creator>Sonc, Monika</creator><relation>documents/doc/P/URN_NBN_SI_doc-P30F7ISO_001.pdf</relation><relation>documents/doc/P/URN_NBN_SI_doc-P30F7ISO_001.txt</relation><format format_type="volume">12</format><format format_type="issue">2</format><format format_type="type">article</format><format format_type="extent">str. 142</format><identifier identifier_type="ISSN">1408-1741</identifier><identifier identifier_type="COBISSID_HOST">704891</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-P30F7ISO</identifier><language>slv</language><publisher>Onkološki inštitut Ljubljana</publisher><source>Onkologija (Ljubljana)</source><rights>BY</rights><subject language_type_id="eng">Congresses</subject><subject language_type_id="eng">Economics</subject><subject language_type_id="eng">Neoplasms</subject><subject language_type_id="eng">Pharmacy service, hospital</subject><subject language_type_id="eng">Therapy</subject><subject language_type_id="eng">Trends</subject><title>Mednarodno strokovno srečanje o pomenu kliničnih farmacevtov pri bolnikih z rakom, Leuven, 26.-28. maj 2008</title></Record>